Requesting pattern of antinuclear antibodies (ANA) and anti-extractable nuclear antigens (ENA) simultaneously by clinicians in a tertiary care hospital in Malaysia.

International guidelines recommend having a positive anti-nuclear antibody (ANA) and clinical suspicion of systemic autoimmune rheumatic diseases (SARD) when requesting ANA subserologies. Compliance with these guidelines by physicians has been questioned in different parts of th…

Criar conta gratuita para acessar o conteúdo completo